Product Name :
Anti-SKR3(Ascrinvacumab Biosimilar) Antibody
Applications:
ELISA,Flow Cyt
Reactivity :
Human ACVRL1/SKR3
Conjugate:
Unconjugated
Advantages :
High lot-to-lot consistencyIncreased sensitivity and higher affinityAnimal-free production
Description:
| Description: Anti-SKR3(Ascrinvacumab Biosimilar) Antibody is a biosimilar antibody directed against Human ACVRL1/SKR3. | Isotype: Human IgG2 | Conjugate: Unconjugated | Specificity: Human ACVRL1/SKR3 | Clonality: Monoclonal | Purity: Recombinant Expression and Affinity purified | Concentration: 1mg/ml | Formation: Liquid, 10mM PBS (pH 7.{{881970-80-5} MedChemExpress|{881970-80-5} Biological Activity|{881970-80-5} In stock|{881970-80-5} supplier} 5) | Storage: Store at –20 °C, (Avoid freeze/thaw cycles)
Description2 :
Anti-SKR3(Ascrinvacumab Biosimilar) Antibody is a biosimilar antibody directed against Human ACVRL1/SKR3.
Immunogen:
Host :
Isotype:
Human IgG2
Purity :
Recombinant Expression and Affinity purified
Buffer :
Storage :
Function:
ELISA: 1:5000-1:20000Flow Cyt: 1:200-1:1000Other tested applications.{{2170983-62-5} site|{2170983-62-5} Purity & Documentation|{2170983-62-5} Formula|{2170983-62-5} custom synthesis} Dilution factors are presented in the form of a range because the optimal dilution is a function of many factors, such as antigen density, permeability, etc.PMID:30020595 The actual dilution used must be determined empirically.